Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$RGGI +20.48% closing the week strong!
MULN - Electric Trucks
$KRTL developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL Recent news can be found here https://www.krtlholding.com/news
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
Read more >>> https://bullish.link/CYCA
Global Medical Response (GMR), a long-time IGAN 1.0 industry customer, has chosen to upgrade its incident command infrastructure to our new IGAN 2.0 AIMS, Cytta Corp (OTCQB:CYCA) is happy to announce (Actionable Intelligence Management System). The ability of GMR to provide critical care and emergency response services in future crisis scenarios around the world will be considerably improved by this strategic choice.
$AITX's Subsidiary, Robotic Assistance Devices, Receives Multiple ROSA Order from EPIC Security Works
Authorized Dealer to Deploy 7 ROSA Devices at Northern California Shopping Center
Detroit, Michigan,, June 07, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the "Company") (OTCPK:AITX), a global leader in AI-driven security and productivity solutions along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced that it has received an order for 7 ROSA security robots. This order is being facilitated through EPIC Security Works, a RAD authorized dealer located in California.
Although not named due to confidentiality agreements, the Company indicated that the end-user is a large retail shopping facility in Northern California. This client has recently experienced an increase in after-hour trespassing, loitering and troublesome threats to employee and guest safety.
"Utilizing the RAD ROSA devices, we can offer the client a very cost-effective, and active solution," said Justin Frazer, Director of Systems at EPIC Security Works. "The ROSAs will be addressing the nagging issue of illegal overnight parking and vagrancy throughout the shopping center property. With RAD's help, we've customized an innovative 24-hour solution by decreasing the reliance on manpower and leaning more into RAD's available technology."
The Company noted that this order marks EPIC Security Works' third order placed with RAD since signing as an authorized dealer in December of 2021, accounting for a total of 17 devices.
Illegal overnight parking and trespassing at shopping malls and retail centers creates grave problems for property management companies. They jeopardize safety, disrupt operations, and hinder customer experiences. Unwanted overnight parking causes congestion, blocks emergency exits, and compromises security. Trespassing invites criminal activities and vandalism, creating an unwelcoming environment. Statistics reported by the National Crime Victimization Survey state that more than 1 in 10 property crimes happen in parking lots, amounting to as many as 1,400 crimes committed in parking lots every day.
"EPIC is being very forward-thinking with their approach to addressing the client's security and safety issues," said Mark Folmer, CPP, PSP, FSyI, President of RAD. "Clients today do not have the budget for increases in manned guarding, but the security problems persist. Combining limited on-site guarding with RAD's AI-powered solutions addresses both issues. We repeatedly see success with ROSA deterring trespassing, and the subscription costs are a fraction of adding more manpower."
The Company stated that the 7 ROSA units are expected to be shipped and be deployed later this summer.
ROSA is a multiple award-winning, compact, self-contained, portable, security and communication solution that can be installed and activated in about 15 minutes. Like other RAD solutions, it only requires power as it includes all necessary communications hardware. ROSA's AI-driven security analytics include human, firearm, vehicle detection, license plate recognition, responsive digital signage and audio messaging, and complete integration with RAD's software suite notification and autonomous response library. Two-way communication is optimized for cellular, including live video from ROSA's dual high-resolution, full-color, always-on cameras. RAD has published three Case Studies detailing how ROSA has helped eliminate instances of theft, trespassing and loitering at car rental locations and construction sites across the country.
About EPIC Security Works
EPIC Security Works is the Bay Area's only concierge style Security Provider. EPIC's well dressed, well groomed, client service professionals are the perfect complement to your business. EPIC Security Works offers a professional alternative to the one size fits all approach of security providers. EPIC Security Works additionally offers security consulting, threat assessment and solutions for commercial and privately owned businesses. To learn more, visit www.epicsecurityworks.com.
AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide a cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers this tremendous costs savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit http://www.aitx.ai, http://www.radsecurity.com,http://www.stevereinharz.com, http://www.radgroup.ai, http://www.raddog.ai, and http://www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
###
Steve Reinharz
949-636-7060
@SteveReinharz
$KRTL Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
https://www.nasdaq.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered
$KRTL an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance $KRTL
$SBIG News: springbig Launches Loyalty Integration with Cova
The two-way integration allows consumers to access their rewards and loyalty benefits at their convenience
BOCA RATON, Fla., June 06, 2023 (GLOBE NEWSWIRE) -- springbig (the "Company") (NASDAQ: SBIG), a leading provider of SaaS-based marketing solutions, today introduced a new integration with Cova, an award-winning cannabis retail platform, which opens springbig up to over 2,000 dispensary locations across the U.S. and Canada.
Cova and springbig have developed an innovative integration that allows consumers to engage with the rewards program at their convenience. Consumers have the option to redeem offers and rewards through their smartphones or with retail staff at checkout. The integration empowers dispensary employees to enroll customers into the loyalty program and redeem springbig rewards at checkout. Additionally, Cova and springbig's collaboration eliminates the possibility of fraud and eradicates the need for manual points reconciliation. Overall, the integration gamifies the loyalty program and brings it into consumers' smartphones while syncing their points and rewards with Cova's point of sale.
"We are thrilled to partner with a purposeful cannabis innovator like Cova," said Jeffrey Harris, CEO of springbig. "Together, we have developed an integration that will add a layer of convenience to the checkout process while keeping customers engaged with their favorite dispensaries. This integration is another example of our unparalleled effort to meet consumers where they are and offer the best customer experience possible."
Cova is a flexible cannabis retail platform that allows dispensaries to broaden their reach and enhance their business. Their award-winning dispensary software streamlines, simplifies the complex and elevates the overall cannabis retail experience. Keeping pace with changing regulations and customer expectations, Cova is committed to shaping the next generation of cannabis retail.
"The two-way integration between Cova and Springbig is a game-changer," said Gary Cohen, CEO of Cova. "It is beneficial to our mutual dispensary clients, their customers, and our companies. The ability to showcase the best rewards for each customer and redeem them quickly from Cova POS provides the cannabis buyer with a seamless experience. The usability of the combined systems is simply unparalleled in the cannabis space."
For more information regarding springbig's latest integration efforts, please visit https://springbig.com/.
About springbig
springbig is a market-leading software platform providing customer loyalty and marketing automation solutions to cannabis retailers and brands in the U.S. and Canada. springbig's platform connects consumers with retailers and brands, primarily through SMS marketing, as well as emails, customer feedback system, and loyalty programs, to support retailers' and brands' customer engagement and retention. springbig offers marketing automation solutions that provide for consistency of customer communication, thereby driving customer retention and retail foot traffic. Additionally, springbig's reporting and analytics offerings deliver valuable insights that clients utilize to better understand their customer base, purchasing habits and trends. For more information, visit https://springbig.com/.
About Cova
Cova software is purpose-built for cannabis retail. The award-winning Cova Point of Sale (POS) is the most recognized in the industry, powering more than 2,000 dispensary locations and helping entrepreneurs across North America simplify compliance and streamline the path to cannabis retail success. Offering industry-leading reliability--with unmatched 100% uptime every 4/20--Cova is backed by highly-praised implementation service and ongoing support. Constantly evolving to stay one step ahead of regulatory changes and help retailers stay compliant and competitive, Cova's software suite--eCommerce, POS, payments, inventory management, and advanced analytics--is easy to use and built to support sustainable growth.
Forward Looking Statements
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of federal securities laws. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "outlook," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would," and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risks and uncertainties described under "Risk Factors" 'of the registration statement on Form S-4, the proxy statement/prospectus relating to the business combination, the Company's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on June 21, 2022, and in the Company's Form 10-Q for the period ended September 30, 2022 filed with the SEC on November 14, 2022, and other documents filed by the Company from time to time with the SEC. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond the control of springbig), and other assumptions, which may cause the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements other than as required by applicable law. The Company does not give any assurance that it will achieve its expectations.
Investor Relations Contact
Ryan Flanagan
ICR Strategic Communications & Advisory
ir@springbig.com
Media Contact
MATTIO Communications
Phoebe Wilson
springbig@mattio.com
$CAFI Game-changing athletic product
Twitter
https://tinyurl.com/2j4yw2ja
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$KRTL's Recent news can be found here https://www.krtlholding.com/news
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL ~ KRTL International is a consultation and distribution company focused on technology and innovations to help greater profitability, social governance, and environmental outcomes to increase and support the 2030 Agenda.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$MGRX read this coverage: https://finance.yahoo.com/news/mangoceuticals-adds-renowned-tech-entrepreneur-140000865.html
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$SBIG News: springbig Announces Closing of $4.0 Million Public Offering
BOCA RATON, Fla., June 01, 2023 (GLOBE NEWSWIRE) -- SpringBig Holdings, Inc. ("springbig" or the "Company") (NASDAQ: SBIG), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs to the cannabis industry, today announced the closing of its $4.0 million public equity offering.
The equity offering, for which Roth Capital Partners acted as sole placement agent, raised gross cash proceeds, before deducting placement agent's fees and other offering expenses, of approximately $3.0 million. In addition, approximately $1.0 million of the Company's existing Senior Secured Convertible Note (the "Note") was cancelled in exchange for shares in the offering at the offering price.
"I am delighted that our secondary offering was fully subscribed and that we were able to complete the transaction as a straight-forward equity offering without the inclusion of warrants or other financial incentives that could potentially have been a future overhang on our stock price," said Jeffrey Harris, CEO and Chairman of springbig. "We now have a stronger balance sheet and adequate capital to fund our growth initiatives in the future and to beyond the point of generating positive operating cash flow."
Springbig continues to make significant progress along its path to profitability. The Company expects results for the second quarter of 2023 to be in line with previously issued guidance, calling for revenue in the range $7.3 million to $7.6 million, representing 15% year-on-year growth at the mid-point, and an Adjusted EBITDA loss in the range $(0.9) million to $(1.2) million, representing further improvement compared with the $(1.3) million Adjusted EBITDA loss reported in Q1.
Paul Sykes, springbig's CFO, added, "We have continued to closely examine our operating expenses in our pursuit of reaching profitability as expediently as possible and have initiated additional cost saving measures during the second quarter, including the elimination of several employee positions. As we enter the third quarter of the fiscal year, we expect our annualized operating expenses to be approximately $25 million, or approximately $6.25 million per quarter, representing a nearly 30% reduction compared with our run-rate during the second half of 2022, and based on current expectations enabling the Company to generate positive Adjusted EBITDA for the third quarter of 2023. Reflecting our revenue growth trajectory, coupled with high gross margins, which reached 81% in the first quarter of 2023, and increasing operating leverage, we expect Adjusted EBITDA margins to expand with each quarter."
Following completion of the public offering, and payment of $750,000 to further reduce the outstanding principal, the amount remaining outstanding on the Company's Senior Secured Convertible Note has now reduced to $6.0 million, with $0.5 million repayable during the remainder of the current year, and the balance repayable in approximately equal payments over a fifteen-month period extending to March 2025.
Following the closing of the public offering, the Company has approximately 40.0 million shares issued. The Company's largest shareholder is Jeffrey Harris, who has a beneficial ownership interest of approximately 15%. The Company has 16.0 million warrants outstanding, dating from its merger, at an exercise price of $11.50 and approximately 0.6 million warrants, held by the Senior Secured Convertible Note holder, at an exercise price of $1.00. The Company also has a Committed Equity Line of Credit with Cantor Fitzgerald, but following the public offering does not have any plans to utilize this in the near future.
About springbig
springbig is a market-leading software platform providing customer loyalty and marketing automation solutions to cannabis retailers and brands in the U.S. and Canada. springbig's platform connects consumers with retailers and brands, primarily through SMS marketing, as well as emails, customer feedback system, and loyalty programs, to support retailers' and brands' customer engagement and retention. springbig offers marketing automation solutions that provide for consistency of customer communication, thereby driving customer retention and retail foot traffic. Additionally, springbig's reporting and analytics offerings deliver valuable insights that clients utilize to better understand their customer base, purchasing habits and trends. For more information, visithttps://springbig.com/.
Forward Looking Statements
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "outlook," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would," and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risks and uncertainties described under "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 28, 2023. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond the control of springbig), and other assumptions, which may cause the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements other than as required by applicable law. The Company does not give any assurance that it will achieve its expectations.
Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with accounting principles generally accepted in the United States (GAAP) included throughout this press release, we have disclosed Adjusted EBITDA, which is a non-GAAP financial measure that we calculate as net income before interest, taxes, depreciation and amortization and further adjustments to exclude unusual and/or infrequent costs. Adjusted EBITDA is a non-GAAP financial measure provided in this press release on a forward-looking basis. The Company does not provide a reconciliation of such forward-looking measure to the most directly comparable financial measure calculated and presented in accordance with GAAP because to do so would be potentially misleading and not practical given the difficulty of projecting event-driven transactional and other non-core operating items in any future period. The magnitude of these items, however, may be significant.
We present Adjusted EBITDA because this metric is a key measure used by our management to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of investment capacity. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management. Management also believes that this measure provides improved comparability between fiscal periods.
Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are as follows:
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; and
Adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us.
Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including net income and our other GAAP results. Also, this non-GAAP financial measure, as determined and presented by the Company, may not be comparable to related or similarly titled measures reported by other companies.
Investor Relations Contact
Ryan Flanagan
ICR Strategic Communications & Advisory
ir@springbig.com
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$SYTA - The global push-to-talk (PTT) market, which includes Push-to-Talk over Cellular (PoC) solutions, is projected to grow at a positive compound annual growth rate (CAGR) of 8.9%, reaching an estimated valuation of US $59.81 billion by 2030.
https://www.tgd8hjs.com/3J67C1/4PR9N3W/
$VZ $T $TMUS $USM #telecom #telecommunications #pushtotalk #PoC #network
$UMGP News: Universal Media Announces AI-Powered Universal Streams Platform
Universal Media Group Inc. (OTC: UMGP) ("UMGP"), an emerging producer and distributor of short and long-form celebrity-based reality content, is pleased to announce the ongoing development of its new streaming platform, “Universal Streams.” In a groundbreaking move for the entertainment industry, the tool will be a state-of-the-art AI-based SVOD (Subscription Video on Demand) platform. The introduction of AI technology into the realm of SVOD platforms represents a significant leap forward in the quest to enhance the user and creator's experience. Universal Media Group wants to use the power of AI to bridge the gap between creators and viewers.
Universal Streams is designed to understand and adapt to individual user preferences, providing personalized recommendations and content suggestions. By leveraging the power of artificial intelligence, the platform aims to offer a more tailored and engaging viewing experience for each user. It is determined to provide advanced Universal Streams Studio tools to help creators from ideation to distribution.
Universal Streams has a creator-focused business model and has removed many barriers creators face when producing and monetizing their content. We are very excited to have teamed up with one of the industry's most innovative technology partners to build and support Universal Streams.
Our team has also expanded to include industry professionals with decades of experience, including with Disney, MGM, Sony, and Paramount. Our expanding team enables us to expand our reach and partner with some of the industry giants providing added value for our productions as well as those by our independent creators. More details regarding our growing distribution network will follow.
Currently listed on the OTC Pink Market (UMGP), Universal Media is in the process of up-listing to the OTCQB. This is in anticipation of our submittal of a listing application to the NASDAQ by the end of our 2023-2024 fiscal year. More to follow.
About Universal Media Group
Universal Media Group (UMGP) is a publicly traded Digital Media Production company. Universal creates an eclectic array of content, including national television network celebrity programming, streaming financial news, and opinion shows. The company will continue to pursue strategic business investments, partnerships, and acquisitions that will ultimately increase profitability and expand the company's reach, focus, and portfolio of business assets.
For further information, visit: https://UMGP.com
Media Details:
Company Name: Universal Media Group
Contact Phone Number: 561.908.3333
Contact Email Address: ms@umediagroupinc.com
Address: 1199 S Federal Hwy, Suite 111, Boca Raton, Fl 33432
Safe Harbor Statement:
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements as predictions, projections, or references to future events, expectations, possibilities, or similar. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. Although the Company believes the expectations reflected in our forward-looking statements are based on reasonable assumptions, the Company cannot give any assurance that its expectations will be attained due to several variable factors. Factors or events that could cause results to differ may emerge, and the Company can't predict all of them. Some of these risks and uncertainties include but are not limited to general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, customer order patterns, changes in consumer trends, and various other factors beyond the Company’s control. Although the Company intends to provide public updates, it undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
$KRTL Axiom utilized the data to complete a full-service package including data acquisition, processing, analysis, technical reporting, and claim management.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$HMBL is closing six figures of commercial revenue already in Latin America.
$HMBL did the first NCAA announcement NFT.
$HMBL is doing the first concert that has NFT tickets in the Oceania region.
$HMBL is a web 3 company.
$HMBL The commercial division has the first government approved wallet in the U.S.
$HMBL Wallet is 4.9 stars and has more features than Meta Mask.
$HMBL Humbl search engine has bothe web 2 and web 3 blockchain capabilities.
$HMBL Search engine can look for verified physical and digital items.
$HMBL the company Receives Funding Commitment of Up To $21 Million as an Initial Step in a Comprehensive Plan To Recapitalize The Company and Pursue Uplisting to a Major Exchange
https://finance.yahoo.com/news/humbl-receives-funding-commitment-21-204500682.html
$AITX's Subsidiary, Robotic Assistance Devices, Books Multiple AVA Expansion Order and Provides Update on Two Major Pilot Programs
Detroit, Michigan, May 30, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the "Company") (OTCPK:AITX), a global leader in AI-driven security and productivity solutions along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced that it has booked an expansion order for 4 AVA autonomous access control security robots. This order is being facilitated through one of RAD's largest authorized dealers.
Although not named due to confidentiality agreements, the Company indicated that the end-user is a top ranked global distribution and supply chain company with over 50 distribution centers. This end-user client has previously purchased 2 AVA devices as announced in a press release dated July 25, 2022. The client is expected to deploy 2 AVA units each at 2 of their nationwide distribution centers. The AVA units are to provide secure access control where previously manned security guards were stationed at the centers' entry gates.
RAD also provided an update on 2 large pilot programs that are expected to conclude over the next few weeks.
RAD ROSA devices have been evaluated at a large, big box retailer with more than 50 distribution centers throughout the United States to serve over 1,000 stores. If the retailer proceeds with an order, RAD anticipates the client initially deploying up to 10 ROSA devices each at 2 of the client's larger distribution centers. This opportunity is being facilitated through one of RAD's largest authorized dealers.
ROSA and RIO are being tested at a prominent shipping and transportation company with over 250 distribution centers throughout the United States. Upon successful completion of the pilot program, the Company anticipates up to 87 ROSA or RIO devices to be deployed by the client in the first year of rollout. This opportunity is being supported by RAD directly.
"It feels so rewarding when our solutions far exceed the clients' expectations," said Steve Reinharz, CEO of AITX and RAD. "Since our beginning, we've made some rather bold claims about our devices' expected performance and cost savings. We love it when the clients begin to see the savings in real dollars, while at the same time their security profile improves. That's the perfect scenario that these clients are experiencing right now."
"Large organizations often request a pilot program, or what's referred to as a 'proof of concept' program, before they can broadly purchase and deploy," said Mark Folmer, CPP, PSP, FSyI, President of RAD. "Advanced technology like ours is new and it often takes time for clients to become comfortable with deploying a robot instead of budgeting for more manpower. These pilot programs can often take months to establish, conduct then conclude. We enjoy sharing our confidence in the solutions and watching how the clients evolve from curious skeptics to inevitable advocates."
The Company stated that the 4 AVA units are expected to be shipped and be deployed later this summer, upon final processing of the received orders.
AVA (Autonomous Verified Access) is a compact and stanchion mountable unit that provides an edge-to-edge 180° field of vision with advanced access control over gates and other controlled points of entry. AVA takes full advantage of the RAD Software Suite providing an ideal solution for logistics and distribution centers, storage yards, parking structures and lots, corporate campuses; anywhere that increased visibility is needed at a fraction of the cost. At ISC West 2022, AVA was named a winner of the SIA New Products and Solutions Awards in the category of Access Control Software, Hardware, Devices and Peripherals.
ROSA is a multiple award-winning, compact, self-contained, portable, security and communication solution that can be installed and activated in about 15 minutes. Like other RAD solutions, it only requires power as it includes all necessary communications hardware. ROSA's AI-driven security analytics include human, firearm, vehicle detection, license plate recognition, responsive digital signage and audio messaging, and complete integration with RAD's software suite notification and autonomous response library. Two-way communication is optimized for cellular, including live video from ROSA's dual high-resolution, full-color, always-on cameras. RAD has published three Case Studies detailing how ROSA has helped eliminate instances of theft, trespassing and loitering at car rental locations and construction sites across the country.
AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers this tremendous cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit http://www.aitx.ai, http://www.stevereinharz.com, http://www.radsecurity.com,http://www.radgroup.ai, and http://www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
###
Steve Reinharz
949-636-7060
@SteveReinharz
$SGTM Orlando, FL, May 25, 2023 (GLOBE NEWSWIRE) -- The Sustainable Green Team, Ltd. (OTCQX: SGTM) (“SGTM” or the “Company”), a provider of environmentally conscious solutions in the arbor care, disposal, and recycling industries strengthens partnership with VRM Global Holdings Pty Ltd. (“VRM”) by increasing their invested interest in SGTM.
SGTM/the-sustainable-green-team-ltd-receives-invested-interest-increase-sxy8ujoa4bks.html" rel="nofollow noopener noreferrer ugc" target="_blank">SGTM/the-sustainable-green-team-ltd-receives-invested-interest-increase-s" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.stocktitan.net/news/SGTM/the-sustainable-green-team-ltd-receives-invested-interest-increase-s
$HMBL has entered into an Equity Financing Agreement with Pacific Lion LLC (Pacific Lion) pursuant to which Pacific Lion agreed to purchase up to $20,000,000 of HUMBL common stock. Pacific Lion also agreed to fund HUMBL up to $800,000 under a Convertible Promissory Note to bridge HUMBL through to the effectiveness of the registration of the shares to be sold under the Equity Financing Agreement. In addition to the transactions with Pacific Lion, HUMBL also raised $220,000 through the sale of common stock and warrants to a group of private investors.
Pursuant to the Equity Financing Agreement, Pacific Lion has agreed to purchase up to $20,000,000 of HUMBL common stock following the receipt of put notices from HUMBL and subject to certain conditions. Pursuant to the Registration Rights Agreement entered into in connection with the Equity Financing Agreement, HUMBL agreed to file a registration statement to register the common stock issuable under the Equity Financing Agreement. Following the effectiveness of the registration statement, if HUMBL elects to cause Pacific Lion to purchase shares, the shares will be purchased at a 15% discount to the lowest closing trade price of HUMBL’s common stock in the prior 10 trading days. The Equity Financing Agreement with Pacific Lion replaces the Equity Financing Agreement previously entered into with GHS Investments, LLC, which has been terminated.
Pursuant to the Convertible Promissory Note issued to Pacific Lion by HUMBL, Pacific Lion has the right to fund up to $800,000. The note bears interest at 6% and is due on May 10, 2024. Following an uplisting to a senior stock exchange, the note will automatically convert at 80% of the uplisting offering price. In addition to the note, the Company also issued a Warrant to Purchase Shares of Common Stock to Pacific Lion. The warrant is exercisable for 500,000 shares for a period of five years at $0.10 per share. In the event that an uplisting to a senior stock exchange does not occur within nine months of the issuance date, the warrant will automatically be canceled. The note is designed to provide a mechanism for Pacific Lion to make regular fundings to cover HUMBL’s working capital needs during the pendency of the registration statement. Pacific Lion funded the first tranche of $100,000 upon the issuance of the note.
HUMBL also sold 100,000,000 shares of common stock and warrants to purchase 100,000,000 shares of common stock for a period of five years at $0.005 to a group of investors for $220,000. The proceeds will be used for general business operations. More information regarding the transaction will be provided in a Form 8-K to be filed with the SEC.
These investments are part of a broader restructuring plan to recapitalize the company, consolidate and retire existing debt and reduce dilution. This restructuring is designed to drive shareholder value and strengthen the balance sheet of the company.
“HUMBL is executing on its core product lines in both its consumer and commercial divisions, and we are ready to drive forward to scaling our revenues through expanded sales and technology bandwidth,” said Brian Foote, CEO of HUMBL. “The capitalization of the company is critical, along with a comprehensive restructuring of debt and share classes, as well as reducing dilution in an effort to drive value for shareholders and prepare the company for uplisting to a major exchange.”
In addition to the investment made by Pacific Lion in HUMBL, the company will also be working with Pacific Lion, a firm that specializes in delivering strategic direct investments and hands-on advisory services to help with the growth of early stage companies. The firm focuses on strategies that help capitalize public companies via retail and institutional investors, along with crowdfunding, equity lines and M+A consulting, with the goal of direct uplistings to a major exchange over a 6-18 month targeted time frame.
“We believe that HUMBL has developed an early-mover advantage in providing Web 3 digital wallets, products and services to consumer and government clients,” said Jacob Fernane, CEO of Pacific Lion. “We believe our access to strategic funding, share structure cleanup, technology and operations augmentation, and more, will allow HUMBL to scale to the levels needed for a major exchange uplist and to rejuvenate its powerful retail shareholder base.”
Another funding strategy the company intends to employ is to file an offering under Regulation A+. Regulation A+ allows companies to raise money under two different tiers. Fully reporting SEC reporting companies such as HUMBL are able to raise up to $75,000,000 on a Tier 2 offering in any 12-month period from the general public. The company hopes to attract a new shareholder base that uses the HUMBL technology and would like to help fund the company directly.
The company will continue in its efforts to secure additional funding and reduce debt in preparation for its attempts to uplist to a major exchange in the future.
About HUMBL
HUMBL is a Web 3 platform with product lines including the HUMBL Wallet™, HUMBL Search Engine™, HUMBL Social™, HUMBL Tickets™, HUMBL Marketplace™ and HUMBL Authentics™. For more information, please visit www.HUMBL.com.
$HMBL These investments are part of a broader restructuring plan to recapitalize the company, consolidate and retire existing debt and reduce dilution. This restructuring is designed to drive shareholder value and strengthen the balance sheet of the company.
“HUMBL is executing on its core product lines in both its consumer and commercial divisions, and we are ready to drive forward to scaling our revenues through expanded sales and technology bandwidth,” said Brian Foote, CEO of HUMBL. “The capitalization of the company is critical, along with a comprehensive restructuring of debt and share classes, as well as reducing dilution in an effort to drive value for shareholders and prepare the company for uplisting to a major exchange.”
https://www.barrons.com/articles/humbl-receives-funding-commitment-of-up-to-21-million-as-an-initial-step-in-a-comprehensive-plan-to-recapitalize-the-company-and-pursue-uplisting-to-a-major-exchange-cda48186?mod=md_stockoverview_news
$HMBL The commercial division has the first government approved wallet in the U.S.
$GSAC .0009/.001 Top Play Next Week--Catalyst_On_The_Way
$GSAC iCAS is a trademark which stands for Intelligent Correctional Automation System.
— TIGRESS🐯 (@og_tigress) May 24, 2023
“A digitally controlled system consisting of computer hardware and recorded software that provides access to sites in a correctional institute, namely, the opening of doors and other points of…
$HMBL About HUMBL - HUMBL is a Web 3 platform with product lines including the HUMBL Wallet™, HUMBL Search Engine™, HUMBL Social™, HUMBL Tickets™, HUMBL Marketplace™ and HUMBL Authentics™. For more information, please visit www.HUMBL.com.
The company also has a commercial blockchain services unit called HUMBL Blockchain Services™ (HBS) for corporate and government clients.
Followers
|
525
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
45886
|
Created
|
02/21/10
|
Type
|
Free
|
Moderator MaxPowerLove$Ihub | |||
Assistants mick Ask$lapper k124Inv RoadRunner3 |
Welcome!
Sad =( Not Funny! But it's True!
Remember, The OTC Market is like Vegas! Treat trading & investing in every penny stocks like Casino gambling!
Check out some of our picks & results in the past:
Recent Plays:
Le2dynasty: Alerted for CBYI in late March @ the point when the stock was at no bid. A few weeks later the PPS reached .0004s (400% gain)
Le2dynasty: Alerted for GRPS (together with KGRI, CBYI) @ .0001s on May 17th...On May 23rd the PPS touched .0012s (1,200% gain)
Le2dynasty: Alerted for CBYI @ .0001s on May 23rd -- early morning & within a few hours, the PPS reached .0003s with mega trading volume-- (71 mil. total trading vol. with 99% buyin' vol.) (300% gain)
Le2dynasty: Alerted for CBYI @ .0002s on May 24rd -- early morning & immediately, the PPS reached .0004s with mega trading volume -- (more than 100 mil. total trading vol. CBYI was the top in top trading vol. on this day) (100% gain)
Le2dynasty: Alerted for EMLL @ .0002s on July 2nd -- early morning & the PPS reached .0004s with mega trading volume -- (more than 260 mil. total trading vol. EMLL became the top in top trading vol. & top in breakout board on this day) (50% gain)
Le2dynasty: Alerted for HIRU @ .0001s on July 3rd & on July 9, HIRU reached .0006s with mega trading volume (600% gain)
Le2dynasty: Alerted for IMDS @.0005s on July 9 @ the pt. when the total trading vol. is below 80 mil. Within 50 minutes later, the PPS reached .0009s, with more than 245 mil. total trading vol. (80% gain) in less than 1 hr. On July 10th another alert was sent out to remind traders/investors & on July 12th, the PPS reached .0026s..that is more than (500% gain) since July 9 alert.
Le2dynasty: Alerted for NVAE in early moring @ the pt. when the stock was @ no bid. PPS then reached .0003s (200% again) with a mega trading vol. (end the trading day with more than 230 mil total trading vol.). Unfortunately, the the stock dropped back to .0001 at closing.
BurntOrang3: : 400-500% gains off of DRGI after the alert
BurntOrang3: : Over 100% gains after my AUCI alert
**** Attention: Mods, Please don't edit the ibox w/o asking me first, b/c there are some kind of coding problems here ...and the IH Greeks ...Especially IH Greek (Dave) had spent a lot of time fixing this. Thank you Dave and thank all the mods here as well ****
Our Associates:
TheKingPennyStock
Daily 000X Plays
Monster Day Traders
Pinky With Potential!
BOTTOM PLAYS! CHART TECH! RESEARCH! STRATEGIES!
"A Dawgg"
Billionaire Boys Club Member Forum (BBCMF)
THE WALL STREET CLUB
$THE WAVE
THE BLUE EXCHANGE
ALERTS, CHARTS, & HOT STOCKS
Momentum Players
Momentum Runners
MOMO'S BREAKOUT BOARD
STOCKGOODIES PLAYS OF THE WEEK
Welcome To The Zoo
~~~TEFFY''S~~~HOT~~~PROFILED~~~PICKS~~~
Another Winning Trade
CASH COW
EZ Traders Forum
NO BRAINERS
StocksDiva Bio Bin
Pinto Beans and Money Making Stock Picks
PINKSHEET Breakout Board!!!
Picks For Every Play
Penny Stock Millionaire
The Van Scan
UNDERVALUED PENNY STOCKS
The Penny Stock Grow Room
Wowza board
Disclaimer: We are not investment advisors. We recommend investors to do their own due diligence. Never invest in any stock unless you can afford to lose your entire investment. Opinions expressed on this board are only opinions.
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
0
|
Posts (Total)
|
45886
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |